Due to the comprehensive investigation of the local and circulating expression profile of the important effectors of the IGF-1 axis in three types of common bone tumors, our study can provide important evidence for the more effective design of chemotherapy treatments based on the inhibitors of this axis. This evidence concerns the gene IGF1 and bone neoplasm.